A three-dose course of the hepatitis B vaccine HEPLISAV-B has fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented ...
Oct 20, 2022
0
2
A study led by Hong Kong Baptist University (HKBU) has revealed the association between rapidly fading antibody levels in some recovered COVID-19 patients and a high plasma concentration of a metabolite called glycylproline ...
Oct 10, 2022
0
45
A research team led by Matthias Preusser from MedUni Vienna's Division of Oncology had already demonstrated that cancer patients benefit from a third vaccination to protect them against COVID. A recent study now also supports ...
Sep 23, 2022
0
42
During the pandemic, physicians used infusions of monoclonal antibodies—antibodies made in a lab—to help patients fight off COVID-19 infections. Now, researchers at UC Davis are trying to create monoclonal antibodies ...
Sep 22, 2022
0
6
A prospective seroprevalence study in the Catalan population underlines the need to get vaccinated despite having been infected, and confirms that hybrid immunity (vaccination plus infection) is more robust and long-lasting. ...
Sep 15, 2022
3
298
Two drugs touted as potential COVID-19 treatments, ivermectin and fluvoxamine, don't do a thing to improve patients' oxygen levels and keep them out of the hospital or the morgue, a new clinical trial has shown.
Aug 18, 2022
1
49
Vaccines have become the most important weapon in the fight against the COVID-19 pandemic, but antibody levels after vaccination decay quickly over time. Therefore, an accurate and affordable antibody rapid test is urgently ...
Jul 28, 2022
0
40
Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial ...
Jul 19, 2022
0
102
People with systemic lupus erythematosus (SLE) who received a "booster" dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent "breakthrough" COVID-19 infection, a new study shows.
Jul 12, 2022
0
72
Using a state-of-the-art method, researchers at DZNE and the University of Texas have succeeded for the first time at unraveling the effects of autoimmune antibodies that are directed against the brain in detail at the atomic ...
Jul 8, 2022
0
58
